F-1/A: Akanda Amends F-1, Registers Shares for Resale

Akanda Corp. filed an amendment to its F-1 registration statement to register 18,761,062 common shares for resale by selling stockholders, stemming from the conversion of $12 million in promissory notes.

Summary

• Akanda Corp. filed Amendment No. 1 to its Form F-1 registration statement on September 29, 2025, to register up to 18,761,062 common shares for resale by selling stockholders.
• These registered shares were issued upon the conversion of principal and interest under outstanding promissory notes totaling an aggregate principal amount of $12,000,000.
• The company detailed recent sales of unregistered securities since January 1, 2022, including 348 Common Shares to the Akanda Bokamoso Empowerment Trust, 658 Common Shares to Halo for $6,582,980 in debt settlement, 760 Common Shares for the acquisition of Holigen Limited, and 2,328 Common Shares to Halo for promissory note satisfaction.
• Other unregistered issuances included 240 restricted stock units to former CEO Tejinder Virk, 88 restricted stock units to former President Dr. Akkar-Schenki, 3,519 Common Shares for a Canadian farming property option payment, 60,251 Common Shares to consultants in May 2024, and 144,930 Class A Special Common Shares to former shareholders of First Towers in September 2025.
• Akanda Corp. entered into a 6-month consulting agreement with IR Agency LLC, commencing September 22, 2025, for marketing and advertising services, with a compensation of $3,500,000 payable by September 19, 2025.
• The company's bylaws and indemnification agreements provide for the indemnification of directors and officers, subject to certain conditions and Ontario law, though the SEC views such indemnification for Securities Act liabilities as against public policy.

Sentiment

Score: 5

Explanation: The filing is largely administrative, detailing the registration of shares for resale and past unregistered issuances. The significant share registration for resale could be seen negatively due to potential dilution, but it also resolves prior debt obligations. The marketing agreement is a substantial expense with uncertain returns. Overall, it's a procedural update with mixed implications, leading to a neutral sentiment.

Positives

• The company's indemnification provisions for directors and officers, supported by Ontario law and contractual agreements, aim to attract and retain qualified management by mitigating personal liability risks.
• The issuance of 348 Common Shares to the Akanda Bokamoso Empowerment Trust demonstrates a commitment to social development initiatives benefiting employees of subsidiaries.
• The conversion of $12,000,000 in promissory notes into common shares resolves existing debt obligations, potentially improving the company's balance sheet structure.

Negatives

• The registration of 18,761,062 common shares for resale by selling stockholders could lead to significant market dilution and downward pressure on the stock price.
• A substantial cash payment of $3,500,000 for a 6-month marketing and advertising consulting agreement with IR Agency LLC represents a significant expense with no guarantee of increased trading volume or stock price appreciation.
• The extensive history of issuing unregistered securities for debt settlement and acquisitions indicates a reliance on equity to manage financial obligations and fund growth, which can be dilutive over time.

Risks

• The SEC's stated opinion that indemnification for liabilities arising under the Securities Act is against public policy and unenforceable, potentially exposing directors and officers to greater personal liability despite company provisions.
• The marketing and advertising services provided by IR Agency LLC explicitly carry no guarantee of market response, increased trading volume, or stock price rise, meaning the $3,500,000 investment may not yield expected returns.
• Potential for significant dilution of existing shareholders' equity due to the resale of 18,761,062 common shares by selling stockholders.
• The company's undertaking to file post-effective amendments for fundamental changes, new prospectuses, or material changes in the plan of distribution implies ongoing regulatory compliance burdens and potential for further disclosures.
• Risk that information provided by the company to the marketing consultant may contain untrue statements or omit material facts, leading to indemnification obligations for the company under the consulting agreement.

Future Outlook

The company anticipates the proposed sale of registered securities to the public as soon as practicable after the registration statement becomes effective. It has undertaken to file post-effective amendments to include required prospectuses, reflect fundamental changes in information, or update material aspects of the plan of distribution. Additionally, a 6-month marketing and advertising campaign with IR Agency LLC is set to commence on September 22, 2025, aimed at communicating company information to the financial community.

Management Comments

• The Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until the Registration Statement shall become effective on such date as the U.S. Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.
• The Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form F-1 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized.

Industry Context

The filing primarily addresses administrative and legal aspects of a share registration and past equity issuances, with limited information to provide a detailed analysis of broader industry trends or competitors. The mention of 'Cannahealth' and the acquisition of 'Holigen Limited' suggests the company operates within the cannabis or health-related sectors, which are subject to specific regulatory and market dynamics.

Comparison to Industry Standards

• The filing does not contain specific financial or operational performance data that would allow for a direct comparison to global industry benchmarks or specific comparable companies. It focuses on legal compliance, share registration, and past equity transactions.

Management Changes

Corporate Governance

Legal Proceedings

• The filing outlines the company's policy to indemnify directors and officers against costs and expenses incurred in civil, criminal, administrative, investigative, or other proceedings, but it does not disclose any specific current legal proceedings against the company.

Related Party Transactions

• On March 15, 2022, the company issued 658 Common Shares to Halo to settle a convertible debenture agreement totaling $6,582,980 (principal $6,559,294 plus accrued interest $23,686).
• On August 14, 2023, the company issued 2,328 Common Shares to Halo in full satisfaction of the remaining outstanding balance of a promissory note payable.
• The filing lists Debt Settlement Agreements with PGC Finco Inc. and Dunstan Holdings Ltd., and Convertible Promissory Notes with PGC Finco Inc. and Dunstan Holdings Ltd., and a Promissory Note with 1353744 B.C. Ltd., suggesting ongoing financial dealings with these entities.

Stakeholder Impact

• Shareholders: Potential for dilution due to the registration of 18,761,062 common shares for resale by selling stockholders, which could impact per-share value.
• Employees: Beneficiaries of the Akanda Bokamoso Empowerment Trust received 348 Common Shares as part of a social development initiative.
• Creditors (Promissory Note Holders): The conversion of $12,000,000 in promissory notes into common shares provides a mechanism for these creditors to monetize their investment.
• Management and Directors: Indemnification agreements offer protection against legal costs, potentially enhancing their security and commitment to the company.

Next Steps

• The registration statement must become effective before the proposed sale of securities to the public can commence.
• The company is obligated to file post-effective amendments to include any required prospectuses, reflect fundamental changes in information, or update material aspects of the plan of distribution.
• The 6-month marketing and advertising services agreement with IR Agency LLC will be active from September 22, 2025.

Key Dates

Recommendation

The filing is primarily administrative, registering a substantial number of shares for resale by existing holders who converted debt. This could lead to dilution and selling pressure. While the company is investing $3.5 million in marketing, the effectiveness is uncertain. There are no new positive operational or financial results to warrant a 'buy,' nor are there severe negative disclosures to suggest a 'sell.' The current information points to a period of structural adjustments and marketing efforts, making a 'hold' a prudent stance until more clarity on operational performance and market absorption of the new shares emerges.

Keywords

Akanda Corp, F-1/A, SEC filing, common shares, promissory notes, resale, dilution, marketing agreement, IR Agency LLC, unregistered securities, indemnification, corporate governance, equity incentive plan, debt settlement, cannabis industry